$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Modified polynucleotides for reducing off-target effects in RNA interference 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-021/04
  • C07H-021/00
출원번호 UP-0019831 (2004-12-22)
등록번호 US-7595387 (2009-10-12)
발명자 / 주소
  • Leake, Devin
  • Reynolds, Angela
  • Khvorova, Anastasia
  • Marshall, William
  • Linsley, Peter S.
출원인 / 주소
  • Dharmacon, Inc.
  • Merck & Co., Inc.
대리인 / 주소
    Kalow & Springut, LLP
인용정보 피인용 횟수 : 83  인용 특허 : 174

초록

Methods and compositions for performing RNA interference with decreased off-target effects are provided The methods and compositions permit effective and efficient applications of RNA interference to applications such as diagnostics and therapeutics through the use of modifications to the siRNA. Un

대표청구항

What is claimed is: 1. A double stranded polyribonucleotide comprising: a. a sense strand comprising a sense region, wherein said sense region comprises: i. a first 5' sense nucleotide, wherein said first 5' sense nucleotide comprises a first 2'-O-alkyl modification, and ii. a second 5' sense nucle

이 특허에 인용된 특허 (174)

  1. Buhr Chris A. ; Matteucci Mark, 2' Modified Oligonucleotides.
  2. Chris A. Buhr ; Mark Matteucci, 2' Modified oligonucleotides.
  3. Manoharan Muthiah ; Cook Phillip Dan, 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides.
  4. Manoharan Muthiah ; Kawasaki Andrew M. ; Cook Phillip Dan ; Fraser Allister S. ; Prakash Thazha P., 2'-O-acetamido modified monomers and oligomers.
  5. Manoharan, Muthiah; Cook, Phillip Dan, 2'-O-aminoethyloxyethyl-modified oligonucleotides.
  6. Cook Phillip Dan ; Manoharan Muthiah ; Kawasaki Andrew Mamoru, 2'-O-aminooxy-modified oligonucleotides.
  7. Cook Phillip Dan ; Guinosso Charles John, 2'-O-modified nucleosides and phosphoramidites.
  8. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-O-modified oligonucleotides.
  9. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  10. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  11. Cook, Phillip Dan; Kawasaki, Andrew Mamoru, 2'modified oligonucleotides.
  12. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Konstanz DEX), 2,′,5′-phosphorothioate oligoadenylates and plant antiviral uses thereof.
  13. Brian C. Froehler ; Arnold J. Gutierrez ; Mark D. Matteucci, 2-Aminopyridine and 2-pyridone C-nucleosides, oligonucleotides comprising, and tests using the same oligonucleotides.
  14. Sproat Brian (Heidelberg DEX) Lamond Angus (Wiesenbach DEX), 2′-O-alkylnucleotides as well as polymers which contain such nucleotides.
  15. Cook P. Dan (Carlsbad CA) Acevedo Oscar L. (San Diego CA) Andrews Robert S. (San Juan Capistrano CA), 3-deazapurines.
  16. Cook P. Dan (Carlsbad CA) Acevedo Oscar L. (San Diego CA) Andrews Robert S. (San Juan Capistrano CA), 3-deazapurines.
  17. Fraser Allister S. ; Manoharan Muthiah ; Cook Phillip Dan ; Jung Michael E. ; Kawasaki Andrew M., Alkylation of alcohols, amines, thiols and their derivatives by cyclic sulfate intermediates.
  18. Manoharan Muthiah ; Cook P. Dan, Amines and methods of making and using the same.
  19. Manoharan, Muthiah; Lonnberg, Harri; Salo, Harri; Virta, Pasi, Aminooxy functionalized oligomers.
  20. Manoharan Muthiah ; Cook Phillip Dan ; Prakash Thazha P. ; Kawasaki Andrew M., Aminooxy-modified oligonucleotides and methods for making same.
  21. Lin Kuei-Ying (Fremont CA) Matteucci Mark (Burlingame CA), Anthraquinone-derivatives oligonucleotides.
  22. David J. Ecker ; Phillip Dan Cook ; Brett P. Monia ; Susan M. Freier ; Yogesh S. Sanghvi, Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
  23. Ecker David J. ; Cook Phillip Dan ; Monia Brett P. ; Freier Susan M. ; Sanghvi Yogesh S., Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
  24. Cowsert Lex M., Antisense inhibiton of human G-alpha-12 expression.
  25. Ian Popoff, Antisense modulation of PTPN2 expression.
  26. Brenda F. Baker ; Lex M. Cowsert ; Brett P. Monia ; Xaoxing S. Xu, Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs).
  27. McKay, Robert; Dean, Nicholas M.; Monia, Brett P.; Nero, Pamela; Gaarde, William A., Antisense oligonucleotide compositions and methods for the modulation of JNK proteins.
  28. Brett P. Monia, Antisense oligonucleotide modulation of raf gene expression.
  29. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Vasseur Jean J. (San Marcos CA) Debart Francoise (Montpellier FRX), Backbone modified oligonucleotide analogues.
  30. Matteucci Mark D. (Burlingame CA) Cao Xiaodong (Carlsbad CA), Binding compentent oligomers containing unsaturated 3′,5′and 2′,5′linkages.
  31. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  32. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  33. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  34. Manoharan Muthiah, Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages.
  35. Manoharan Muthiah, Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages.
  36. Gonye, Gregory E.; Hanafey, Michael K.; LaRossa, Robert A.; Rafalski, J. Antoni; Van Dyk, Tina K., Cellular arrays for the identification of altered gene expression.
  37. Innis, Michael A.; Reinhard, Christoph J.; Zuckermann, Ronald N., Chimeric antisense oligonucleotides and cell transfecting formulations thereof.
  38. Innis, Michael A.; Reinhard, Christoph J.; Zuckermann, Ronald N., Chimeric antisense oligonucleotides and cell transfecting formulations thereof.
  39. Phillip Dan Cook ; Thomas Bruice ; Charles John Guinosso ; Andrew Mamoru Kawasaki ; Richard Griffey, Compositions and methods for modulating RNA.
  40. Cook Phillip D. (Carlsbad CA) Bruice Thomas (Carlsbad CA) Guinosso Charles J. (Carlsbad CA) Kawasaki Andrew M. (Oceanside CA), Compositions for inhibiting RNA activity.
  41. Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Compounds having phosphorodithioate linkages of high chiral purity.
  42. Cook Phillip D. (San Marcos CA) Teng Kelly (San Diego CA), Conjugated 4′-desmethyl nucleoside analog compounds.
  43. Walder Joseph A. ; Walder Roxanne Y. ; Eder Paul S. ; Dagle John M., DNA molecules stabilized by modifications of the 3'-terminal phosphodiester linkage.
  44. Li Li-Chun ; Liu Lawrence C. ; Murray Michael A., DRAM with edge sense amplifiers which are activated along with sense amplifiers internal to the array during a read cycl.
  45. Manoharan Muthiah ; Cook Phillip Dan ; Bennett Clarence Frank, Derivatized oligonucleotides having improved uptake and other properties.
  46. Muthiah Manoharan ; Phillip Dan Cook ; Clarence Frank Bennett, Derivatized oligonucleotides having improved uptake and other properties.
  47. Froehler Brian (Belmont CA) Matteucci Mark (Burlingame CA), Enhanced triple-helix and double-helix formation with oligomers containing modified purines.
  48. Brian Froehler ; Rick Wagner ; Mark Mattencci ; Robert J. Jones ; Arnold J. Gutierrez ; Jeff Pudlo, Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines.
  49. Froehler Brian (Belmont CA) Wagner Rick (Belmont CA) Matteucci Mark (Burlingame CA) Jones Robert J. (Millbrae CA) Gutierrez Arnold J. (Sandy Lane CA) Pudlo Jeff (Burlingame CA), Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines.
  50. Matulic-Adamic Jasenka ; Beigelman Leonid ; Karpeisky Alexander ; Jarvis Thale ; Usman Nassim ; DiRenzo Anthony ; Wincott Francine, Enzymatic nucleic acids containing 5'-and/or 3'-cap structures.
  51. Cook Phillip Dan, Gapped 2'-modified oligonucleotides.
  52. Fire, Andrew; Kostas, Stephen; Montgomery, Mary; Timmons, Lisa; Xu, SiQun; Tabara, Hiroaki; Driver, Samuel E.; Mello, Craig C., Genetic inhibition by double-stranded RNA.
  53. Manoharan, Muthiah; Cook, Phillip Dan; Prakash, Thazha P.; Mohan, Venkatraman, Guanidinium functionalized oligonucleotides and method/synthesis.
  54. Peter C. Roberts ; Bruce L. Frank ; David E. Szymkowski ; John S. Mills GB; John Goodchild ; Jia L. Wolfe ; Robert E. Kilkuskie ; Isobel M. Greenfield GB; Veronica Sullivan GB, HPV-specific oligonucleotides.
  55. Cook Phillip Dan ; Sanghvi Yogesh Shantilal, Heteroatomic oligonucleoside linkages.
  56. Teng Kelly (San Diego CA) Sanghvi Yogesh S. (San Marcos CA) Cook Phillip Dan (San Marcos CA), Heteroatomic oligonucleoside linkages.
  57. Melcher, Thorsten; McFarland, Keith Charles; Gan, Li; Ye, Shiming; Gonzalez-Zulueta, Mirella, High-throughput transcriptome and functional validation analysis.
  58. Alberto Haces ; Valentina C. Ciccarone, Highly packed polycationic ammonium, sulfonium and phosphonium lipids.
  59. Haces Alberto (Gaithersburg MD) Ciccarone Valentina C. (Gaithersburg MD), Highly packed polycationic ammonium, sulfonium and phosphonium lipids.
  60. Haces Alberto ; Ciccarone Valentina C., Highly packed polycationic ammonium, sulfonium and phosphonium lipids.
  61. Haces Alberto ; Ciccarone Valentina C., Highly packed polycationic ammonium, sulfonium and phosphonium lipids.
  62. Haces, Alberto; Ciccarone, Valentina C., Highly packed polycationic ammonium, sulfonium and phosphonium lipids.
  63. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  64. Metelev Valeri,RUX ; Agrawal Sudhir, Hybrid oligonucleotide phosphorothioates.
  65. Valeri Metelev RU; Sudhir Agrawal, Hybrid oligonucleotide phosphorothioates.
  66. Agrawal Sudhir (46G Brandywine Dr. Shrewsbury MA 01545) Leiter Josef M. E. (111 Hicks St. ; #25C Brooklyn NY 11201) Palese Peter (414 Highwood Ave. Leonia NJ 07605) Zamecnik Paul C. (29 LeBeaux Dr. S, Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions.
  67. Cowsert Lex M. (Carlsbad CA) Ecker David J. (Carlsbad CA), Inhibition of influenza viruses by antisense oligonucleotides.
  68. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  69. Agrawal Sudhir, Inverted chimeric and hybrid oligonucleotides.
  70. Agrawal Sudhir (Shrewsbury MA), Inverted chimeric and hybrid oligonucleotides.
  71. Agrawal Sudhir, Inverted chimeric oligonucleotides.
  72. Dunlay, R. Terry; Taylor, D. Lansing; Gough, Albert H.; Giuliano, Kenneth A., Machine readable storage media for detecting distribution of macromolecules between nucleus and cytoplasm in cells.
  73. Rolle Thomas E. (Dubuque IA), Method for removing coatings which create hazardous byproducts.
  74. Agrawal Sudhir (Shrewsbury MA) Diasio Robert B. (Birmingham AL) Zhang Ruiwen (Birmingham AL), Method of down-regulating gene expression.
  75. Agrawal, Sudhir; Diasio, Robert B.; Zhang, Ruiwen, Method of down-regulating gene expression.
  76. Agrawal, Sudhir; Diasio, Robert B.; Zhang, Ruiwen, Method of down-regulating gene expression.
  77. Stec Wojciech J. (Lodz PLX) Uznanski Bogdan (Lodz CA PLX) Bergot B. John (Redwood City CA) Hirschbein Bernard L. (San Francisco CA) Fearon Karen L. (Union City CA), Method of synethesizing sulfurized oligonucleotide analogs.
  78. Douglas L. Cole ; Vasulinga Ravikumar, Method of synthesizing phosphorothioate oligonucleotides.
  79. Alul Rushdi (Columbia MD), Methods and compositions for sequence-specific hybridization of RNA by 2′-5′oligonucleotides.
  80. Muthiah Manoharan, Methods for the preparation of conjugated oligomers.
  81. Manoharan Muthiah ; Cook P. Dan, Methods of synthesis and use.
  82. Froehler Brian ; Wagner Rick ; Matteucci Mark ; Jones Robert J. ; Gutierrez Arnold J. ; Pudlo Jeff, Methods of using oligomers containing modified pyrimidines.
  83. Palsson Bernhard .O slashed.., Methods, compositions and apparatus for cell transfection.
  84. Knebel, Gunther, Micro plate with transparent base.
  85. Manns Roy L. (Marshfield Hills MA) Kolb Alfred J. (Madison CT) Effertz Bernard S. (Meriden CT), Microplate forming wells with transparent bottom walls for assays using light measurements.
  86. Sundaramoorthi Swaminathan ; Mark Matteucci ; Jeff Pudlo ; Robert J. Jones, Modified internucleoside linkages (II).
  87. Swaminathan Sundaramoorthi ; Matteucci Mark ; Pudlo Jeff ; Jones Robert J., Modified internucleoside linkages (II).
  88. Matteucci Mark (Burlingame CA) Jones Robert J. (Daly City CA) Munger John (San Francisco CA), Modified internucleoside linkages having one nitrogen and two carbon atoms.
  89. Manoharan, Muthiah; Cook, Phillip Dan; Guinosso, Charles J., Modified oligonucleotides.
  90. Agrawal, Sudhir, Modified protein kinase A-specific oligonucleotides and methods of their use.
  91. Hanecak,Ronnie C.; Anderson,Kevin P.; Bennett,C. Frank; Chiang,Ming Yi; Brown Driver,Vickie L.; Ecker,David J.; Vickers,Timothy A.; Wyatt,Jacqueline R., Modulation of telomere length by oligonucleotides having a G-core sequence.
  92. Balch William J. ; Hogan Michael E. ; Mendoza Leopoldo G., Multiplexed molecular analysis apparatus and method.
  93. Cook P. Dan (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), N-2 substituted purines.
  94. Lin Kuei-Ying (Fremont CA) Matteucci Mark (Burlingame CA), Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods.
  95. Cook Philip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA), Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression.
  96. Thompson, James; Beigelman, Leonid; McSwiggen, James; Karpeisky, Alexander; Bellon, Laurent; Reynolds, Mark; Zwick, Michael; Jarvis, Thale; Woolf, Tod; Haeberli, Peter; Matulic-Adamic, Jasenka, Nucleic acid molecules with novel chemical compositions capable of modulating gene expression.
  97. Iyer, Radhakrishnan P.; Jin, Yi; Roland, Arlene; Zhou, Wenqiang, Nucleic acid-based compounds and methods of use thereof.
  98. Reese Colin Bernard,GBX, Nucleoside phosphorothioate derivatives, synthesis and use thereof.
  99. Klinman, Dennis; Verthelyi, Daniela; Ishii, Ken; Mond, James J.; Gursel, Mayda, Oligodeoxynucleotide and its use to induce an immune response.
  100. Otvos Laszlo,HUX ; Sagi Janos,HUX ; Szemzo Attila,HUX ; Sagi Gyula,HUX ; Szabolcs Ottone,HUX ; Ruff Eva,HUX ; Ebinger Katalin,HUX ; Tudos Ferencne,HUX ; Fellegvari Iren,HUX, Oligodeoxynucleotides containing 5-alkyl, 5-(1-alkenyl)- and 5-(1-alkynl) pyrimidines.
  101. Cook Phillip Dan ; Sanghvi Yogesh S. ; Sprankle Kelly G. ; Ross Bruce S. ; Griffey Rich H., Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions.
  102. Miller Paul S. ; Ts'o Paul O.P., Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids.
  103. Sanghvi Yogesh S. ; Cook Phillip Dan, Oligonucleoside linkages containing adjacent nitrogen atoms.
  104. Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms.
  105. Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  106. Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  107. Simon Lionel N. ; Miller Paul S. ; Ts'o Paul O. P., Oligonucleotide analogues having improved stability at acid pH.
  108. Tullis Richard H. (La Jolla CA), Oligonucleotide therapeutic agent and method of making same.
  109. Tullis Richard H., Oligonucleotide therapeutic agent and methods of making same.
  110. Froehler Brian (Belmont CA) Jones Robert J. (Daly City CA), Oligonucleotides containing 5-propynyl pyrimidines.
  111. Cook Phillip D. (San Marcos CA) Ramasamy Kanda S. (Laguna Hills CA) Manoharan Muthiah (Carlsbad CA), Oligonucleotides containing N-2 substituted purines.
  112. Muthiah Manoharan ; Venkatraman Mohan, Oligonucleotides having A-DNA form and B-DNA form conformational geometry.
  113. Stec Wojciech J.,PLX ; Grajkowski Andrzej,PLX ; Uznanski Bogdan,PLX, Oligonucleotides having R.sub.p and S.sub.p linkages at predetermined locations.
  114. Cook Phillip Dan, Oligonucleotides having chiral phosphorus linkages.
  115. Cook Phillip Dan, Oligonucleotides having chiral phosphorus linkages.
  116. Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides having phosphorothioate linkages of high chiral purity.
  117. Phillip Dan Cook ; Muthiah Manoharan, Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages.
  118. Brian C. Froehler ; Arnold J. Gutierrez ; Mark D. Matteucci, Oligonucleotides including 2-aminopyridine and 2-pyridone C-nucleoside units.
  119. Froehler Brian (Belmont CA), Oligonucleotides with inverted polarity.
  120. Heinz Hartmut Seliger DE; Flavio Ramalho Ortigao DE; Hannelore Rosch DE; Rudi Rosch DE; Bernd Krist DE, Oligoribonucleotide and ribozyme analogs with terminal 3'-3' and/or 5'-5' linkages.
  121. Crooke Stanley T., Oligoribonucleotides for cleaving RNA.
  122. Scaringe Stephen A., Orthoester protecting groups.
  123. Scaringe, Stephen, Orthoester protecting groups.
  124. Scaringe Stephen ; Caruthers Marvin H., Orthoester protecting groups in RNA synthesis.
  125. Scaringe Stephen ; Caruthers Marvin H., Orthoester reagents for use as protecting groups in oligonucleotide synthesis.
  126. Cook Phillip Dan ; Manoharan Muthiah, Phosphorothioate oligonucleotides having modified internucleoside linkages.
  127. Cook, Phillip Dan; Manoharan, Muthiah, Phosphorothioate oligonucleotides having modified internucleoside linkages.
  128. Stein Cy ; Lederman Seth ; Sullivan Gregory, Phosphorothioate oligonucleotides that bind to the V3-loop and uses thereof.
  129. Imbach Jean-Louis,FRX ; Rayner Bernard,FRX, Phosphorothioate triester oligonucleotides and method of preparation.
  130. Cook Philip D. (Carlsbad CA) Guinosso Charles J. (Carlsbad CA), Polyamine conjugated oligonucleotides.
  131. Caruthers Marvin H. ; Brill Wolfgang K.-D,DEX ; Yau Eric ; Ma Michael ; Nielsen John,DKX, Polynucleotide phosphorodithioate compounds.
  132. Just George,CAX ; Xin Zhili,CAX ; Marsault Eric,CAX ; Jin Yi,CAX, Preparation of chiral phosphorothioate oligomers.
  133. Iyer Radhakrishnan P. ; Devlin Theresa ; Habus Ivan ; Yu Dong ; Agrawal Sudhir, Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same.
  134. Yau Eric K. (Kirkland WA), Process for preparing phosphorothioate oligonucleotides.
  135. Cook Phillip Dan ; Sanghvi Yogesh S. ; Sprankle Kelly G. ; Ross Bruce S. ; Griffey Rich H. ; Springer Robert H., Process for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom.
  136. Matteucci Mark ; Jones Robert J. ; Lin Kuei-Ying, Pyrimidine derivatives.
  137. Lin Kuei-Ying ; Matteucci Mark D., Pyrimidine derivatives and oligonucleotides containing same.
  138. Kuei-Ying Lin ; Mark D. Matteucci, Pyrimidine derivatives for labeled binding partners.
  139. Lin Kuei-Ying ; Matteucci Mark D., Pyrimidine derivatives for labeled binding partners.
  140. Matteucci Mark D. (Burlingame CA) Jones Robert J. (Millbrae CA) Lin Kuei-Ying (Fremont CA), Pyrimidine derivatives for labeled binding partners.
  141. Matteucci Mark D. ; Jones Robert J., Pyrimidine derivatives for labeled binding partners.
  142. Acevedo Oscar L. ; Dunkel Martin G.,DEX ; Cook Phillip Dan, Pyrimidine nucleoside compounds and oligonucleoside compounds containing same.
  143. Oscar L. Acevedo ; Martin G. Dunkel DE; Phillip Dan Cook, Pyrimidine nucleosides.
  144. Manoharan Muthiah ; Mohan Venkatraman ; Boswell Herb, RNA targeted 2'-modified oligonucleotides that are conformationally preorganized.
  145. Sabatini, David M., Reverse transfection method.
  146. Goodchild John, Ribozymes having 2'-O substituted nucleotides in the flanking sequences.
  147. Anuschirwan Peyman DE; Eugen Uhlmann DE; Matthias Mag DE; Gerhard Kretzschmar DE; Matthias Helsberg DE; Irvin Winkler DE, Stabilized oligonucleotides and their use.
  148. Cook Phillip Dan (Carlsbad CA) Manoharan Muthiah (Carlsbad CA) Ramasamy Kanda S. (Laguna Hills CA), Substituted purines and oligonucleotide cross-linking.
  149. Cook Phillip Dan ; Manoharan Muthiah ; Ramasamy Kanda S., Substituted purines and oligonucleotide cross-linking.
  150. Cook Philip Dan ; Kawasaki Andrew M., Sugar modified oligonucleotides that detect and modulate gene expression.
  151. Cook Phillip Dan (Carlsbad CA) Kawasaki Andrew Mamoro (Oceanside CA), Sugar modified oligonucleotides that detect and modulate gene expression.
  152. Pierre Martin CH; Karl-Heinz Altmann CH; Phillip Dan Cook ; Brett P. Monia, Sugar-modified gapped oligonucleotides.
  153. Cook P. Dan ; Acevedo Oscar L. ; Andrews Robert S., Synthesis of 3-deazapurines.
  154. Cole Douglas L. ; Ravikumar Vasulinga T. ; Cheruvallath Zacharia S., Synthesis of sulfurized 2'-substituted oligonucleotides.
  155. Dunlay R. Terry ; Taylor D. Lansing, System for cell-based screening.
  156. Dunlay, R. Terry; Taylor, D. Lansing, System for cell-based screening.
  157. Dunlay, R. Terry; Taylor, D. Lansing, System for cell-based screening.
  158. Dunlay, R. Terry; Taylor, D. Lansing, System for cell-based screening.
  159. Giuliano, Kenneth; Kapur, Ravi, System for cell-based screening.
  160. Kenneth Giuliano ; Ravi Kapur, System for cell-based screening.
  161. Rubin, Richard A.; Giuliano, Kenneth A.; Gough, Albert H.; Dunlay, R. Terry, System for cell-based screening.
  162. Sammak, Paul; Duensing, Thomas D.; Rubin, Richard A., System for cell-based screening.
  163. Manoharan, Muthiah, Targeted Oligonucleotide conjugates.
  164. Manoharan Muthiah, Targeted oligonucleotide conjugates.
  165. Cook Phillip D. (Carlsbad CA) Manoharan Muthiah (Carlsbad CA), Thiol-derivatized nucleosides.
  166. Cook Phillip Dan ; Manoharan Muthiah, Thiol-derivatized nucleosides and oligonucleosides.
  167. Cook Phillip Dan ; Manoharan Muthiah, Thiol-derivatized oligonucleosides.
  168. Cook Phillip Dan ; Manoharan Muthiah, Thiol-derivatized oligonucleotides.
  169. Arrow Amy ; Dale Roderic M. K. ; Woolf Tod Mitchell, Three component chimeric antisense oligonucleotides.
  170. Arrow Amy ; Dale Roderic M.K. ; Woolf Tod Mitchell, Three component chimeric antisense oligonucleotides.
  171. Arrow, Amy; Dale, Roderic M. K.; Woolf, Tod Mitchell, Three component chimeric antisense oligonucleotides.
  172. Sabatini, David M., Transfection method and uses related thereto.
  173. Bartelmez, Stephen H.; Iversen, Patrick L., Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method.
  174. Hafeman Dean G. (Hillsborough CA) Humphries Gillian M. K. (Los Altos CA), Ultraviolet radiation transparent multi-assay plates.

이 특허를 인용한 특허 (83)

  1. Woolf, Tod, Double-stranded oligonucleotides.
  2. Woolf, Tod; Wiederholt, Kristin, Double-stranded oligonucleotides.
  3. Woolf, Tod; Wiederholt, Kristin, Double-stranded oligonucleotides.
  4. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen, Functional and hyperfunctional siRNA.
  5. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen, Functional and hyperfunctional siRNA.
  6. Brown, David; Ford, Lance P.; Jarvis, Richard A.; Pallotta, Vince; Pasloske, Brittan L., High potency siRNAS for reducing the expression of target genes.
  7. Woolf, Tod M.; Kamens, Joanne; Khvorova, Anastasia; Salomon, William, Inhibition of MAP4K4 through RNAI.
  8. Kamens, Joanne; Khvorova, Anastasia, Inhibition of PCSK9 through RNAI.
  9. Kamens, Joanne; Khvorova, Anastasia, Inhibition of PCSK9 through RNAi.
  10. Zamore, Phillip D.; Hutvagner, Gyorgy; Schwarz, Dianne; Simard, Martin, Methods and compositions for enhancing the efficacy and specificity of RNA silencing.
  11. Zamore, Phillip D.; Hutvagner, Gyorgy; Schwarz, Dianne; Simard, Martin, Methods and compositions for enhancing the efficacy and specificity of RNA silencing.
  12. Zamore, Phillip D.; Hutvagner, Gyorgy; Schwarz, Dianne; Simard, Martin, Methods and compositions for enhancing the efficacy and specificity of RNA silencing.
  13. Zamore, Phillip D.; Hutvagner, Gyorgy; Schwarz, Dianne; Simard, Martin, Methods and compositions for enhancing the efficacy and specificity of RNA silencing.
  14. Zamore, Phillip D.; Hutvagner, Gyorgy; Schwarz, Dianne; Simard, Martin, Methods and compositions for enhancing the efficacy and specificity of RNAi.
  15. Zamore, Phillip D.; Schwarz, Dianne, Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA.
  16. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  17. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  18. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  19. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  20. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  21. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  22. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  23. Burel, Sebastien, Methods of predicting toxicity.
  24. Pavco, Pamela A.; Kamens, Joanne; Woolf, Tod M.; Salomon, William; Khvorova, Anastasia, Modified RNAi polynucleotides and uses thereof.
  25. Spayd, Katie Jansen; Karpilow, Jon; Wakefield, John K., Modified cell lines for increasing lentiviral titers.
  26. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Miller, Michelle; Bulock, Karen G., Neutral nanotransporters.
  27. Chi, Sung Wook; Jang, Eun-Sook, Nucleic acid inducing RNA interference modified for preventing off-target, and use thereof.
  28. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  29. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  30. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  31. Woolf, Tod; Taylor, Margaret, Oligonucleotide compositions with enhanced efficiency.
  32. Avkin-Nachum, Sharon; Feinstein, Elena, Oligonucleotide compounds comprising non-nucleotide overhangs.
  33. Avkin-Nachum, Sharon; Feinstein, Elena, Oligonucleotide compounds comprising non-nucleotide overhangs.
  34. Samarsky, Dmitry; Woolf, Tod M., Phagocytic cell delivery of RNAI.
  35. Woolf, Tod M.; Kamens, Joanne; Salomon, William; Khvorova, Anastasia, RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality.
  36. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James; Bulock, Karen G., RNA interference in dermal and fibrotic indications.
  37. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James; Bulock, Karen G., RNA interference in dermal and fibrotic indications.
  38. Libertine, Lyn; Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, RNA interference in ocular indications.
  39. Libertine, Lyn; Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James; Pavco, Pamela A., RNA interference in ocular indications.
  40. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  41. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  42. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Cardia, James, RNA interference in skin indications.
  43. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, RNAi targeting CNTD2.
  44. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, RNAi targeting SEC61G.
  45. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, RNAi targeting ZNF205.
  46. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  47. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  48. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  49. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  50. Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Cardia, James, Reduced size self-delivering RNAi compounds.
  51. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting apolipoprotein B (APOB).
  52. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting beta secretase (BACE).
  53. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting connective tissue growth factor (CTGF).
  54. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2).
  55. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting fructose-1, 6-bisphosphatase 1 (FBP1).
  56. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting glucagon receptor (GCGR).
  57. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting histamine receptor H1.
  58. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting myeloid differentiation primary response gene (88) (MYD88).
  59. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting myeloid differentiation primary response gene (88) (MYD88).
  60. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting proto-oncogene MET.
  61. Templin, Michael V.; Vaish, Narendra K.; Polisky, Barry A.; Houston, Jr., Michael E., UNA oligomer structures for therapeutic agents.
  62. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting KRAS.
  63. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1).
  64. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1).
  65. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting amyloid beta (A4) precursor protein (APP).
  66. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting apolipoprotein B (APOB).
  67. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting beta secretase (BACE).
  68. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting connective tissue growth factor (CTGF).
  69. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting connective tissue growth factor (CTGF).
  70. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cyclin dependent kinase 11 (CDK11).
  71. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cyclin-dependent kinase 4 (CDK4).
  72. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B).
  73. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting gremlin.
  74. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting histamine receptor H1.
  75. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting interleukin-1 receptor-associated kinase 4(IRAK4).
  76. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting kinase insert domain receptor (KDR).
  77. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting proto-oncogene MET.
  78. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase).
  79. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen, siRNA targeting spleen tyrosine kinase.
  80. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting spleen tyrosine kinase.
  81. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting superoxide dismutase 1 (SOD1).
  82. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting tie-2.
  83. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting tumor protein 53 (p53).
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로